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clear lack of an evidence base for predicting and mitigating against fur-
ther proliferation of Zika throughout the world.
Mosquito-borne disease epidemiology is shaped by the mosquito's
capacity to transmit the virus, known as the vectorial capacity, which
has been formulated into a quantitative framework (Liu-Helmersson
et al. 2016). Temperature is a key factor delimiting this capacity,Zika
Flavivirus
Aedes
MosquitoesZika virus (ZIKV) is a ﬂavivirus transmitted via the bites of infected
Aedes mosquitoes, although non-vector-borne transmission has also
been documented (sexual andmaternofetal transmission and transmis-
sion through transfusion) (Musso and Gubler, 2016). Until the recent
outbreaks, ZIKV had a known restricted circulation in Africa and Asia,
but with only sporadic human cases reported. ZIKV infection was con-
sidered relatively benign, with the majority of infections causing no or
mild symptoms. The most common clinical manifestations include
rash, fever, arthralgia, and conjunctivitis. In 2007, Yap, Micronesia, was
the ﬁrst Zika outbreak outside Africa and Asia, but which was small
and with no cases requiring hospitalization (Duffy et al. 2009). Howev-
er, in 2013 a large Zika outbreak occurred in French Polynesia and then
in New Caledonia in 2014 (Cao-Lormeau et al. 2014; Dupont-Rouzeyrol
et al. 2015), with ﬁrst signs of the virus being associated with severe
neurological complications, including Guillain-Barré syndrome (Cao-
Lormeau et al. 2016) and microcephaly in newborns (Schuler-Faccini
et al. 2016), in a small percentage of cases. The virus then spread pro-
gressively to the Cook Islands, Easter Island and Solomon Islands prior
to the explosive epidemic observed in Brazil and the Americas. In May
2015, the ﬁrst local cases of Zika were recorded in Brazil and by Decem-
ber the number of cases had surpassed 1.5 million. On February 2016,
the World Health Organization declared Zika as a public health emer-
gency of international concern and as of June 1st 60 countries reported
on-going transmission.
The proliﬁc spread of ZIKV, its apparent increased virulence and our
general lack of knowledge about its epidemiology is causing alarm and
panic globally. Currently, we are witnessing serve and volley exchanges
between the WHO and the “Rio Olympics later” International.2016.06.009.
. This is an open access article underCommunity over the Olympics threat of Zika, bearing testament to the
impacting not only on mosquito population densities but more impor-
tantly the speed of viral dissemination within themosquito. As temper-
atures decrease, the virus dissemination rate slows and the probability
of the mosquito surviving until it becomes infectious decreases. In the
tropics, temperatures are sufﬁciently clement to sustain transmission,
whereas in temperate regions temperatures are only sufﬁciently high
in the summer months. The summer in Europe is thus the risk season
when autochthonous transmission is sustainable, as observed on sever-
al occasions over last few years for dengue virus, a related ﬂavivirus.
Europe is gearing up for the summer, kicking off with the European
Football Cup, and increasingly concernedwith a ZIKV version of theMa-
deira 2012 epidemic where the ﬁrst European dengue epidemic oc-
curred since the 1920s (Alves et al. 2013). In this context, Rocklöv et
al., 2016 provide a much needed quantitative assessment of the poten-
tial threat of a Zika epidemic in Europe. As outlined in the European
Centre for Disease Prevention and Control (ECDC) guidelines, the ﬁrst
step is to assess the location and level of the threat, thereby enabling
local health authorities to take appropriate action (ECDC, 2016).
Rocklöv et al., 2016 provide exactly this. The minimum requirements
for epidemic potential are the occurrence of a competentmosquito spe-
cies, the virus and temperatures that enable transmission capacity.
Human migration from areas with circulating ZIKV into European
areas with Aedes spp. (notably Aedes albopictus and to a rarer extent
Aedes aegypti) during the warmer summer months offer epidemic po-
tential. The authors combine ZIKV prevalence data in countries current-
ly epidemic for Zika, with international travel volume into Europe
embedded in an epidemiological (vectorial capacity based) model of
transmission potential. This enables the ﬁrst quantitative estimates of
the potential extent of virus invasion and subsequent epidemic poten-
tial in site-speciﬁc localities in Europe setwithin a temporality reﬂecting
seasonal warming – the “when” and the “where” epidemic potential.
Whether there will be an epidemic somewhere in Europe this sum-
mer remains to be seen, but at the very least the article by Rocklöv et al.,
2016 provides a quantitative basis uponwhich local authorities can base
strategiesmitigating against the spread of ZIKV this year and for years tothe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
18 R.E. Paul / EBioMedicine 9 (2016) 17–18come. ZIKV is not going away and has joined the two other currently
prevalent arboviruses, Dengue and Chikungunya in going global and
thus temperate regions must take the threat of an epidemic seriously
and develop long-term strategies. It can only be hoped that local health
authorities, aided by ECDC, co-authors of the paper, take heed of the
quantitative predictions and develop appropriate, sustainable strategies
to prevent and combat the threat of arboviral outbreaks in Europe and
elsewhere.
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